Akums Drugs & Pharmaceuticals Ltd (AKUMS)

NSE · Healthcare · Pharmaceuticals & Biotechnology · Pharmaceuticals

₹731.70

As of 30 Oct 2026 close.

Facts from reported results and exchange filings. Not investment advice.

Share price

Prices load here as you scroll to them.

Last close ₹731.70 on 30 Oct 2026. The share price traded between ₹409.30 and ₹838.80 (intraday) over the last 12 months.

The closes as a table

DateClose

Key figures

1-year range (intraday)

Last close ₹731.70

Low ₹409.30High ₹838.80

Market cap₹11,341 crorelast close × shares
P/E39.5on reported profit, last four quarters
Net profit₹293 crlast 12 months
Return on equity8.4%year to Mar 2026
EBITDA margin12.0%year to Mar 2026
Debt to equity0.05year to Mar 2026
Net margin5.9%year to Mar 2026
Dividend yield0.42%last 12 months, with a ₹2 special dividend

Price trend

Revenue and profit

RevenueNet profit₹ crore
-2,00002,0004,0006,000
YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue3,6723,6554,1784,1184,359
Net profit-251981344256
EBITDA margin-2.4%8.0%3.0%11.0%12.0%
Borrowings39561956588157

₹ crore. Over three years, compounded: revenue grew 6.0% a year, net profit grew 37.7% a year.

Recent filings

Questions about Akums Drugs & Pharmaceuticals Ltd

What is Akums Drugs & Pharmaceuticals Ltd's market value?

Akums Drugs & Pharmaceuticals Ltd's market value is ₹11,341 crore as of 30 Oct 2026 close: the last close times the shares in issue. Its P/E is 39.5, the last close over earnings per share for the last four reported quarters.

When are Akums Drugs & Pharmaceuticals Ltd's next results?

Akums Drugs & Pharmaceuticals Ltd's next results are listed for 2 Nov 2026 (the exchange's notice: Financial Results). Dates are as the company announced them, on the list of 30 Oct 2026.

Who are Akums Drugs & Pharmaceuticals Ltd's largest named shareholders?

In the shareholding pattern for the quarter ended 30 Sep 2026, the largest named holders above 1% were: AKUMS MASTER TRUST (Sanjeev Jain and Sandeep Jain) (promoter group) 40.79%; Sandeep Jain (promoter group) 17.24%; Sanjeev Jain (promoter group) 17.23%. Percentages are of all shares.

Go further with AKUMS

Free to start: test a trading idea on AKUMS's real prices after costs, or open the full deep dive with ten years of numbers, red flags and management's record.

Same industry

The largest companies in the same industry (Pharmaceuticals), by market value.

Browse companies

The companies before and after this one, A to Z, and the lists it is in.

How these figures are worked out

The net profit for the last 12 months is the four latest reported quarters, so it can differ from the newest year's in the table below.